Erik Sims
Corporate Officer/Principal bei OCUPHIRE PHARMA, INC.
Aktive Positionen von Erik Sims
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Corporate Officer/Principal | 01.06.2023 | - |
| Comptroller/Controller/Auditor | 01.04.2021 | 31.05.2023 |
Karriereverlauf von Erik Sims
Ehemalige bekannte Positionen von Erik Sims
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2016 | - |
Ausbildung von Erik Sims
| Walsh College | Masters Business Admin |
| University of Michigan-Flint | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |